François Miceli

François Miceli

Direttore/Membro del Consiglio presso Aptys Pharmaceuticals SAS

60 anni
Health Technology
Technology Services
Producer Manufacturing

Profilo

François Miceli is the founder of LMD SAS, which was founded in 1999.
He held the position of Chief Operating Officer from 1999 to 2003.
Currently, he holds director positions at I.P.H - Industries Plastiques Holding SAS, Aptys Pharmaceuticals SAS, Millendo Therapeutics SAS, ISORG SA, Perfect Memory SAS, Primo1D SA, FineHeart SA, IXALTIS SAS, Sonethic SA, and is a Senior Managing Partner at Sofimac Innovation SAS since 2017.
He is also a Member-Supervisory Board at Axess Vision Technology SA and NEURONAX SA. In the past, he held the position of Chief Executive Officer at Imaxio SA from 2003 to 2011, Chief Executive Officer at IDEXX Laboratories Italia Srl from 1997 to 1998, Chief Executive Officer at Zophis SASU from 2011 to 2013, Chairman & Chief Executive Officer at Axcell Biotechnologies from 2004 to 2011, and Chairman at ERYTech Pharma SA from 2002 to 2009.
He also held various director positions at Lytess SA, CERADROP SA, BEG Ingénierie SA, Biom'Up SA, Theranexus SA, BW Ideol, ElsaLys Biotech SAS, Microphyt SA, APD Advanced Perfusion Diagnostics SA, Amolyt Pharma SAS, Applications Plastiques Thermoformes Extrudes SA, Syndicat De L’Industrie Du Médicament Vétérinaire, Crossject SA, Aston SA, ReproPharm SA, Eydo Pharma SAS, and Clonatec SA. He was the General Manager at IDEXX France SA from 1995 to 1997 and Director-European Operations at Synbiotics Europe SAS from 1998 to 2000.
He has an undergraduate degree from INSEAD and Universite Paris Est.
Creteil Val De Marne and also attended Institut des Hautes Etudes de Défense Nationale.

Posizioni attive di François Miceli

SocietàPosizioneInizio
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -
Tutte le posizioni attive di François Miceli

Precedenti posizioni note di François Miceli

SocietàPosizioneFine
░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░ -
░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di François Miceli

Formazione di François Miceli

INSEAD Undergraduate Degree
Universite Paris Est Creteil Val De Marne Undergraduate Degree
Institut des Hautes Etudes de Défense Nationale Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di François Miceli

Relazioni

70

Relazioni di 1° grado

43

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa4
IDEXX LABORATORIES, INC.

Health Technology

CROSSJECT

Health Technology

THERANEXUS

Health Technology

VALBIOTIS

Health Technology

Aziende private36

Producer Manufacturing

Finance

Technology Services

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Producer Manufacturing

Health Technology

Industrial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Distribution Services

Health Technology

Industrial Services

Health Technology

Technology Services

Health Technology

Health Technology

Distribution Services

Health Technology

Technology Services

Electronic Technology

Electronic Technology

Health Technology

Health Technology

Producer Manufacturing

Health Technology

Technology Services

Health Technology

Commercial Services

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. François Miceli
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA